Our integrated aptamer platform, including aptamer discovery and optimization, shortens the drug development period from leading compound discovery to preclinical candidate selection.
"Development of preclinical candidate within 3 years"
Based on the integrated aptamer platform, two innovative therapeutic platforms, AlloMAp and BiFAp, have been established.